MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 41 filers reported holding MEI PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $37,000 | -80.1% | 62,583 | -10.2% | 0.00% | – |
| Q4 2021 | $186,000 | +1.6% | 69,700 | +5.2% | 0.00% | – |
| Q3 2021 | $183,000 | -15.7% | 66,224 | -13.1% | 0.00% | – |
| Q2 2021 | $217,000 | -14.6% | 76,216 | +2.8% | 0.00% | – |
| Q1 2021 | $254,000 | +19.2% | 74,143 | -8.2% | 0.00% | – |
| Q4 2020 | $213,000 | +9.8% | 80,807 | +30.0% | 0.00% | – |
| Q3 2020 | $194,000 | -9.3% | 62,176 | +19.9% | 0.00% | – |
| Q2 2020 | $214,000 | +269.0% | 51,851 | +44.2% | 0.00% | – |
| Q1 2020 | $58,000 | -13.4% | 35,967 | +31.0% | 0.00% | – |
| Q4 2019 | $67,000 | -18.3% | 27,454 | -44.7% | 0.00% | – |
| Q3 2019 | $82,000 | -77.7% | 49,647 | -66.5% | 0.00% | – |
| Q2 2019 | $368,000 | +418.3% | 148,184 | +529.6% | 0.00% | – |
| Q1 2019 | $71,000 | -87.1% | 23,536 | -88.7% | 0.00% | – |
| Q4 2018 | $549,000 | -65.8% | 208,113 | -44.1% | 0.00% | – |
| Q3 2018 | $1,603,000 | -18.7% | 372,156 | -25.6% | 0.00% | -100.0% |
| Q2 2018 | $1,971,000 | +428.4% | 500,326 | +177.6% | 0.00% | – |
| Q1 2018 | $373,000 | -22.0% | 180,213 | -20.9% | 0.00% | – |
| Q4 2017 | $478,000 | +12.2% | 227,932 | +43.1% | 0.00% | – |
| Q3 2017 | $426,000 | -4.5% | 159,241 | -14.8% | 0.00% | – |
| Q2 2017 | $446,000 | +107.4% | 186,813 | +40.5% | 0.00% | – |
| Q1 2017 | $215,000 | +593.5% | 132,959 | +510.5% | 0.00% | – |
| Q4 2016 | $31,000 | -93.3% | 21,778 | -91.7% | 0.00% | – |
| Q3 2016 | $460,000 | +15233.3% | 261,447 | +10100.8% | 0.00% | – |
| Q2 2016 | $3,000 | -25.0% | 2,563 | -30.5% | 0.00% | – |
| Q1 2016 | $4,000 | 0.0% | 3,686 | +47.4% | 0.00% | – |
| Q4 2015 | $4,000 | -84.6% | 2,501 | -85.4% | 0.00% | – |
| Q3 2015 | $26,000 | +550.0% | 17,085 | +583.4% | 0.00% | – |
| Q2 2015 | $4,000 | -88.9% | 2,500 | -87.7% | 0.00% | – |
| Q1 2015 | $36,000 | -85.9% | 20,370 | -66.3% | 0.00% | – |
| Q4 2014 | $256,000 | -38.5% | 60,370 | 0.0% | 0.00% | – |
| Q3 2014 | $416,000 | +51.3% | 60,370 | +38.9% | 0.00% | – |
| Q2 2014 | $275,000 | +21.7% | 43,478 | +112.7% | 0.00% | – |
| Q1 2014 | $226,000 | +133.0% | 20,445 | +66.8% | 0.00% | – |
| Q4 2013 | $97,000 | -59.4% | 12,258 | -42.5% | 0.00% | – |
| Q3 2013 | $239,000 | – | 21,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |